THYROID HORMONE CONTROL OF CARDIAC SODIUM/POTASSIUM ATPASE EXPRESSION
THYROID HORMONE CONTROL OF CARDIAC SODIUM/POTASSIUM ATPASE EXPRESSION
批准号:
6241593
负责人:
FARAMARZ ISMAIL-BEIGI
金额:
$17.82万
依托单位国家:
美国
项目类别:
财政年份:
1997
资助国家:
美国
项目状态:
已结题
起止时间:
1997-04-01 至 1998-03-31
关键词:
RNase protection assay bioenergetics enzyme activity gene expression genetic mapping genetic transcription genetic translation hormone regulation /control mechanism hyperthyroidism hypothyroidism laboratory rat messenger RNA molecular cloning muscle cells myocardium nuclear runoff assay nucleic acid sequence posttranscriptional RNA processing sodium potassium exchanging ATPase thyroid hormones triiodothyronine
中文摘要
Na+,K+-ATPase是一种普遍存在的质膜结合酶,其
连续函数对正则函数是至关重要的
几乎所有的动物细胞。在心肌中,这种酶代表
洋地黄苷的细胞受体及其活性
受到甲状腺激素(T3)作用的显著刺激。在
目前,我们探讨了生理学的分子基础。
T3对心肌Na~+,K~+-ATPase表达的调控作用
实现以下三大目标:
1.验证心肌Na~+,K~+-ATPase的诱导
T3亚基的mRNAs是在转录水平上调节的。
A.确定心肌Na+,K+-ATPase转录增强的作用
促进α-1、α-2和β-1基因的表达
T3。
1)如果响应是转录的,则使用最近的
描述了将表达质粒直接注射到
收缩心肌,鉴定5‘-DNA序列
字母1的侧翼区域。字母2。和β1基因,这些基因介导了
在体心肌组织中对T3的转录反应。
2)如果T_3诱导Na~+,K~+-ATPase亚基增加的机制
MRNAs是转录后的,然后检验序列
包含在α1、α2和β1 RNA的3‘-非翻译区
转录本介导T3诱导的细胞内mRNAs的稳定
活体心肌。
2.验证Na+,K+-ATPase基因表达受调控的假说
在异位同种异体心脏中被T3所取代,因此不依赖于
收缩功。
A.检测Na+,K+-ATPase亚单位mRNA蛋白和α1、α2
异位心脏中的酶活性。
B.测定甲状腺激素缺乏和过量对Na+的影响,
K+-ATPase在异位心脏中的表达
3.检验各种mRNAbeta1物种存在差异的假设
在心肌中受T3调节,它们表现出不同的
翻译效率。
A.确定不同的mRNAbeta1物种在
低、高、甲亢大鼠心肌组织,并测定其相对分子质量。
每种mRNAbeta1的翻译效率。
对Na~+,K~+-ATPase表达和功能调控的认识
与几种人类疾病的发病机制有关,包括
充血性心力衰竭、高血压、肥胖和甲状腺状态改变。
英文摘要
Na+, K+ -ATPase is a ubiquitous plasma membrane-bound enzyme whose
continuous function is of critical importance tot he normal function of
virtually all animal cells. In the myocardium the enzyme represents the
cellular receptor for digitalis glycosides and its activity is
significantly stimulated by the action of thyroid hormone (T3). In the
present application we explore the molecular basis for the physiological
control of myocardial Na+, K+-ATPase expression by T3, and plan to
accomplish the following three major goals:
1. Test the hypothesis that the induction of myocardial Na+, K+ -ATPase
subunit mRNAs by T3 is mediated at the transcriptional level.
a. Determine the role of enhanced transcription of cardiac Na+, K+-ATPase
genes in the enhancement of alpha1, alpha2, and beta1 mRNA expression by
T3.
1) If the response is transcriptional, then employing the recently
described method of direct injection of expression plasmids into the
contracting ventricular myocardium, identify DNA sequences in the 5'-
flanking regions of the alpha1. alpha2. and beta1 genes that mediate the
transcriptional response to T3 in myocardial tissue in vivo.
2) If the mechanism of the T3-induced increase of Na+, K+ -ATPase subunit
mRNAs is post-transcriptional then test the hypothesis that sequences
contained in the 3'-untranslated region of alpha1, alpha2, and beta1 RNA
transcripts mediate the T3-induced stabilization of the mRNAs in the
myocardium in vivo.
2. Test the hypothesis that Na+, K+ -ATPase gene expression is regulated
by T3 in the heterotopic isografted heart and is hence independent of
contractile work.
a. Examine Na+, K+ -ATPase subunit mRNA protein and alpha1 and alpha2
enzyme activity in the heterotopic heart.
b. Determine the effect of thyroid hormone deficiency and excess on Na+,
K+ -ATPase expression in the heterotopic heart.
3. Test the hypothesis that various mRNAbeta1 species are differentially
regulated by T3 in the myocardium and that they exhibit distinct
translational efficiencies.
a. Identify the different mRNAbeta1 species that are expressed in the
myocardium of hypo-, eu-, and hyperthyroid rats, and determine the relative
translational efficiency of each mRNAbeta1 species.
Understanding of the regulation of Na+, K+ -ATPase expression and function
is of relevance to the pathogenesis of several human diseases including
congestive heart failure, hypertension, obesity, and altered thyroid state.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Molecular engineering of complementary glucose-responsive conformational switches in insulin and glucagon
-
批准号:10263301
-
项目类别:
-
资助金额:$58.36万
-
财政年份:2020
-
负责人:FARAMARZ ISMAIL-BEIGI
-
依托单位:
Molecular endocrinology and principles of diabetes therapeutics: application to ultra-stable insulin analogs
-
批准号:10155480
-
项目类别:
-
资助金额:$61.97万
-
财政年份:2020
-
负责人:FARAMARZ ISMAIL-BEIGI
-
依托单位:
Molecular engineering of complementary glucose-responsive conformational switches in insulin and glucagon
-
批准号:10443890
-
项目类别:
-
资助金额:$49.03万
-
财政年份:2020
-
负责人:FARAMARZ ISMAIL-BEIGI
-
依托单位:
Novel PET Imaging of Glucose Transport
-
批准号:7730065
-
项目类别:
-
资助金额:$37.68万
-
财政年份:2009
-
负责人:FARAMARZ ISMAIL-BEIGI
-
依托单位:
Novel PET Imaging of Glucose Transport
-
批准号:8110071
-
项目类别:
-
资助金额:$33.47万
-
财政年份:2009
-
负责人:FARAMARZ ISMAIL-BEIGI
-
依托单位:
Novel PET Imaging of Glucose Transport
-
批准号:7884582
-
项目类别:
-
资助金额:$37.3万
-
财政年份:2009
-
负责人:FARAMARZ ISMAIL-BEIGI
-
依托单位:
Novel PET Imaging of Glucose Transport
-
批准号:8322155
-
项目类别:
-
资助金额:$33.47万
-
财政年份:2009
-
负责人:FARAMARZ ISMAIL-BEIGI
-
依托单位:
Regulation of Glut 1 Function
-
批准号:6685004
-
项目类别:
-
资助金额:$32.51万
-
财政年份:2003
-
负责人:FARAMARZ ISMAIL-BEIGI
-
依托单位:
Regulation of Glut 1 Function
-
批准号:6771818
-
项目类别:
-
资助金额:$24.86万
-
财政年份:2003
-
负责人:FARAMARZ ISMAIL-BEIGI
-
依托单位:
Regulation of Glut 1 Function
-
批准号:7070598
-
项目类别:
-
资助金额:$24.28万
-
财政年份:2003
-
负责人:FARAMARZ ISMAIL-BEIGI
-
依托单位:
Regulation of Glut 1 Function
-
批准号:6882034
-
项目类别:
-
资助金额:$24.86万
-
财政年份:2003
-
负责人:FARAMARZ ISMAIL-BEIGI
-
依托单位:
THYROIDAL REGULATION OF CARDIAC SODIUM/POTASSIUM ATPASE EXPRESSION AND ENERGETICS
-
批准号:6564805
-
项目类别:
-
资助金额:$17.41万
-
财政年份:2002
-
负责人:FARAMARZ ISMAIL-BEIGI
-
依托单位:
THYROID HORMONE CONTROL OF CARDIAC SODIUM/POTASSIUM ATPASE EXPRESSION
-
批准号:6302114
-
项目类别:
-
资助金额:$17.41万
-
财政年份:2000
-
负责人:FARAMARZ ISMAIL-BEIGI
-
依托单位:
ACCORD
-
批准号:8062075
-
项目类别:
-
资助金额:$24.55万
-
财政年份:1999
-
负责人:FARAMARZ ISMAIL-BEIGI
-
依托单位:
THYROID HORMONE CONTROL OF CARDIAC SODIUM/POTASSIUM ATPASE EXPRESSION
-
批准号:6109470
-
项目类别:
-
资助金额:$17.41万
-
财政年份:1999
-
负责人:FARAMARZ ISMAIL-BEIGI
-
依托单位:
THYROID HORMONE CONTROL OF CARDIAC SODIUM/POTASSIUM ATPASE EXPRESSION
-
批准号:6272556
-
项目类别:
-
资助金额:$17.87万
-
财政年份:1998
-
负责人:FARAMARZ ISMAIL-BEIGI
-
依托单位:
REGULATION OF GLUT1 GLUCOSE TRANSPORTER EXPRESSION
-
批准号:2145179
-
项目类别:
-
资助金额:$17.95万
-
财政年份:1994
-
负责人:FARAMARZ ISMAIL-BEIGI
-
依托单位:
REGULATION OF GLUT1 GENE EXPRESSION BY HYPOXIA
-
批准号:6380762
-
项目类别:
-
资助金额:$22.25万
-
财政年份:1994
-
负责人:FARAMARZ ISMAIL-BEIGI
-
依托单位:
REGULATION OF GLUT1 GENE EXPRESSION BY HYPOXIA
-
批准号:2616197
-
项目类别:
-
资助金额:$20.37万
-
财政年份:1994
-
负责人:FARAMARZ ISMAIL-BEIGI
-
依托单位:
REGULATION OF GLUT1 GENE EXPRESSION BY HYPOXIA
-
批准号:2905520
-
项目类别:
-
资助金额:$20.98万
-
财政年份:1994
-
负责人:FARAMARZ ISMAIL-BEIGI
-
依托单位:
海外基金